Dr. Olusunmade Adekunle, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2929 |
Maura Quinn, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-869-5583 Fax: 727-861-5147 |
Francis Edward Toscano, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2929 |
Mrs. Nataly Vanessa Saldana, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2929 |
Dr. Helen Edith Yaworski, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Bayonet Point Emergency Department, 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2929 |
Harry Borno, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2929 |
Dr. Alexandre David Pierrot, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 917-692-5174 |
Kenneth Mark Degraaf, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14000 Fivay Rd, Hudson, FL 34667 Phone: 727-819-2929 |
News Archive
For a skin cell to do its job, it must turn on a completely different set of genes than a liver cell — and keep genes it doesn't need switched off. One way of turning off large groups of genes at once is to send them to "time-out" at the edge of the nucleus, where they are kept quiet. New research from Johns Hopkins sheds light on how DNA gets sent to the nucleus' far edge, a process critical to controlling genes and determining cell fate.
Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.
ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced that Columbia University Medical Center has achieved 100 implants of the ATS 3f(R) Aortic Bioprosthesis. Based on the precept that 'Form Follows Function,' the ATS 3f Aortic Bioprosthesis is a revolutionary next generation stentless pericardial aortic tissue valve that is unlike any other valve.
King's College London was today announced as the first partner to adopt the NVIDIA DGX-2 and NVIDIA Clara platform.
For over a decade, hormone therapy (HT) has been a hot topic in medicine. Unfortunately, women are still confused and concerned about using HT after two federally-funded studies linked HT to potentially serious health risks.
› Verified 8 days ago